Presepsin作为院外心脏骤停患者自主循环恢复后评估预后与早期先天免疫反应的生物标志物
本研究为回顾性分析,纳入165例自主循环恢复超过12小时的院外心脏骤停患者和100名健康对照,在复苏后第0、1、3天检测血浆Presepsin和降钙素原水平。结果显示,院外心脏骤停患者Presepsin水平高于健康对照;28天存活者和神经功能预后良好者Presepsin及降钙素原水平持续低于28天非存活者和神经功能预后不良者。第0、1、3天不同Presepsin截断值对28天死亡率和神经功能预后良好具有与降钙素原相似的预后价值。Presepsin与降钙素原在第1天与CD14表达呈低度正相关,与HLA-DR+单核细胞百分比呈强负相关。结论认为Presepsin是院外心脏骤停患者自主循环恢复后的独立预后因素,监测其水平可能有助于评估预后和早期先天免疫反应异常。
要点
- 在165例自主循环恢复超过12小时的院外心脏骤停患者中,血浆Presepsin水平高于100名健康对照。
- 复苏后前3天内,28天存活者和神经功能预后良好者的Presepsin和降钙素原水平持续低于28天非存活者和神经功能预后不良者。
- 第0、1、3天不同Presepsin截断值对28天死亡率和神经功能预后良好具有与降钙素原相似的预后价值。
- 第1天Presepsin和降钙素原与CD14表达呈低度正相关,与HLA-DR+单核细胞百分比呈强负相关。
- 血浆Presepsin浓度是院外心脏骤停患者自主循环恢复后的独立预后因素,监测Presepsin水平可能有助于评估预后和早期先天免疫反应异常。
适用人群与场景
- 纳入165例院外心脏骤停且自主循环恢复超过12小时的患者,以及100名健康个体。
- 研究场景为城市大学三级医院急诊科。
研究设计与关键结果
- 研究类型为回顾性分析,纳入165例自主循环恢复超过12小时的院外心脏骤停患者和100名健康个体,无干预。
- 在复苏后第0天及自主循环恢复后第1天和第3天检测血浆Presepsin和降钙素原水平,院外心脏骤停患者Presepsin水平高于健康个体。
- 复苏后前3天内,28天存活者和神经功能预后良好者的Presepsin和降钙素原水平持续低于28天非存活者和神经功能预后不良者。
- 第0、1、3天不同Presepsin截断值对28天死亡率和神经功能预后良好显示出与降钙素原相似的预后价值。
- 与对照相比,院外心脏骤停患者CD14表达在第1天升高、第3天开始下降,而HLA-DR+单核细胞百分比在第1天和第3天降低。
- 第1天Presepsin和降钙素原与CD14表达呈低度正相关,与HLA-DR+单核细胞百分比呈强负相关。
证据类型、等级与局限
- 证据类型:回顾性分析。
- 血浆Presepsin浓度是院外心脏骤停患者自主循环恢复后的独立预后因素,并与单核细胞CD14和HLA-DR表达异常相关。
- 监测Presepsin水平可能有助于评估自主循环恢复后早期预后和受损的先天免疫反应。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于自主循环恢复超过12小时的院外心脏骤停患者,可在第0、1、3天检测血浆Presepsin水平,其不同截断值对28天死亡率和神经功能预后良好具有与降钙素原相似的预后价值。
- Presepsin与降钙素原在第1天与CD14表达呈低度正相关、与HLA-DR+单核细胞百分比呈强负相关,提示其可能反映早期先天免疫反应异常。
- 作者认为监测Presepsin水平可能有助于评估自主循环恢复后早期预后和受损的先天免疫反应。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: After return of spontaneous circulation, patients who experienced out-of-hospital cardiac arrest present an impaired innate immune response that resembles sepsis. Presepsin, a new biomarker for sepsis, has not been studied in out-of-hospital cardiac arrest patients. This study explored the role of presepsin in evaluating the prognosis and early innate immune alteration of out-of-hospital cardiac arrest patients after return of spontaneous circulation by observing presepsin levels, CD14, and human leukocyte antigen-DR expression on monocytes.
DESIGN: Retrospective analysis.
SETTING: The emergency department of an urban university tertiary hospital.
PARTICIPANTS: One hundred sixty-five out-of-hospital cardiac arrest patients with return of spontaneous circulation more than 12 hours, and 100 healthy individuals.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Plasma presepsin and procalcitonin levels were tested after resuscitation (day 0) and on days 1 and 3 after return of spontaneous circulation. Presepsin levels were higher in out-of-hospital cardiac arrest patients than in healthy individuals. In the first 3 days, presepsin and procalcitonin levels were persistently lower in 28-day survivors and patients with favorable neurologic outcome patients than in 28-day nonsurvivors and patients with unfavorable neurologic outcome. On days 0, 1, and 3, different cut-off values of presepsin showed prognostic value for 28-day mortality and favorable neurologic outcomes similar to procalcitonin. CD14 and human leukocyte antigen-DR expression on monocytes were analyzed by flow cytometry. Compared with controls, CD14 expression in out-of-hospital cardiac arrest patients increased on day 1 and began to decrease on day 3, whereas human leukocyte antigen-DR+ monocyte percentages decreased on days 1 and 3. Presepsin and procalcitonin had a low positive correlation with CD14 expression and a strong negative correlation with human leukocyte antigen-DR+ monocyte percentages on day 1.
CONCLUSIONS: Plasma presepsin concentrations are independent prognostic factors for out-of-hospital cardiac arrest patients after return of spontaneous circulation and are correlated with abnormal CD14 and human leukocyte antigen-DR expression on monocytes. Monitoring presepsin levels may be helpful for evaluating the prognosis and impaired innate immune response in the early period after return of spontaneous circulation.
参考来源
- Qi Z, Zhang Q, Liu B, et al. Presepsin As a Biomarker for Evaluating Prognosis and Early Innate Immune Response of Out-of-Hospital Cardiac Arrest Patients After Return of Spontaneous Circulation. Crit Care Med. 2019. PMID: 30985453. doi:10.1097/CCM.0000000000003764
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。